Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children
- Conditions
- Separation Anxiety DisorderSocial Anxiety DisorderGeneralized Anxiety Disorder
- Interventions
- Other: Attentional Bias Modification Treatment (ABMT) - ActiveOther: Attentional Bias Modification Treatment - PlaceboBehavioral: Cognitive Behavioral Group TherapyBehavioral: Psychoeducational Control Intervention
- Registration Number
- NCT01687764
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Brief Summary
The objective of this project is to test the combination of active or placebo Attentional Bias Modification Treatment (ABMT) to either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for anxiety disorders in children.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 90
- Primary diagnosis of Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SeAD) or Social Anxiety Disorder (SoAD) according to KSADS-PL psychiatric interview
- Other psychiatric disorder that causes more impairment and suffering than GAD, SeAD or SoAD in the clinical evaluation
- Current or previous treatment (behavioral or pharmacological) for a psychaitric disorder in childhood
- IQ < 70 (Raven)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description CBGT+ABMT(placebo) Cognitive Behavioral Group Therapy - CBGT+ABMT(active) Attentional Bias Modification Treatment (ABMT) - Active - CBGT+ABMT(placebo) Attentional Bias Modification Treatment - Placebo - PCI+ABMT(active) Psychoeducational Control Intervention - CBGT+ABMT(active) Cognitive Behavioral Group Therapy - PCI+ABMT(active) Attentional Bias Modification Treatment (ABMT) - Active - PCI+ABMT(placebo) Attentional Bias Modification Treatment - Placebo - PCI+ABMT(placebo) Psychoeducational Control Intervention -
- Primary Outcome Measures
Name Time Method Clinical Global Impression - Improvement Scale (CGI-I) / dichotomous Endpoint (week-10) and 6-month follow-up Percentage of subjects with less than 2 points in the CGI-I scale in week 10 and in 6-month follow-up
Pediatric Anxiety Rating Scale (PARS) / continuous Endpoint (week 10) and 6-month follow-up Score change on Pediatric Anxiety Rating Scale (PARS) from baseline to week 10 and to 6-month follow-up
- Secondary Outcome Measures
Name Time Method Screen for Children and Anxiety Related Emotional Disorders (SCARED) Endpoint (week-10) and 6-months follow-up Score change in SCARED child and parent versions from baseline to week 10 and 6-months follow-up
Childhood Depression Inventory (CDI) Endpoint (week-10) and 6-month follow-up Score change in CDI from baseline to week-10 and to 6-month follow-up
Spence Children's Anxiety Scale (SCAS) Endpoint (week-10) and 6-month follow-up Score change in SCAS from baseline to week-10 and to 6-month follow-up
Biological measures Endpoint (week-10) and 6-month follow-up Change in biological measures from baseline to week-10 and to 6-month follow-up
Swanson, Nolan, and Pelham scale - Version IV (SNAP-IV) Endpoint (week-10) and 6-month follow-up Score change in SNAP-IV from baseline to week-10 and 6-month follow-up
Neuropsychological measures Endpoint (week-10) and 6-month follow-up Change in neuropsychological measures from baseline to week-10 and 6-month follow-up
Trial Locations
- Locations (4)
Federal University of Rio Grande do Sul / Hospital de ClÃnicas de Porto Alegre (HCPA)
🇧🇷Porto Alegre, Rio Grande do Sul, Brazil
National Institute of Mental Health (NIMH)
🇺🇸Bethesda, Maryland, United States
University of Queensland
🇦🇺Brisbane St Lucia, Queensland, Australia
Tel-Aviv University
🇮🇱Tel-Aviv, Israel